Why the study?
Does serum cardiac troponin T differ between full-term neonates with transient myocardial ischemia and healthy newborns or adults?
Does serum cardiac troponin T differ between full-term neonates with transient myocardial ischemia and healthy newborns or adults?
Cardiac troponin T levels are naturally higher in neonates compared to adults, and do not significantly differentiate between term infants with and without transient myocardial ischemia.
Answers are grounded in this paper and cite their sources.
Neonatal TnT exceeds adult norms without distinguishing transient ischemia; supports age-specific ranges but leaves diagnostic utility open.
Cardiac troponin T (TnT) is a regulatory contractile protein whose detection in the circulation has been shown to be a specific and sensitive marker for ischemic myocardial cell injury both in adult and pediatric populations. We measured serum cardiac TnT in 15 consecutive full-term neonates presenting with bradycardia and electrocardiographic features of transient myocardial ischemia. Their median TnT concentrations (0.5 microg/l, range 0.01-0.37) were statistically comparable to our laboratory reference values for healthy term newborns (median 0.17 microg/l, range 0.01-0.42) (p = NS), but significantly higher with respect to our reference limits for healthy adults (median 0.01 micog/l, range 0.01-0.1) (p < 0.05). Our data demonstrate high TnT levels in neonates during the first days of life with respect to adults and similar TnT concentrations in term infants with and without TMI.
No takes yet. Share an insight, caveat, or question.
Trevisanuto et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: